154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors

• David Page,
• Eric Lutz,
• Ivan Borrello,
• Daniela Bota,
• Paul Swiecicki,
• Lakshmi Rudraraju,
• Elizabeth DeOliveira,
• Amanda Seiz,
• Monil Shah,
• Celine Colmenares,
• Beverly Dan Fu,
• Collin Brummel,
• Chad Brenner,
• Nicole Fredrich,
• Eleni Efstatihiou,
• Kimberly Noonan

Affiliations

David Page

Aff319 grid.240531.1000000040456863XEarle A. Chiles Research Institute, Providence Portland Medical Center Portland OR USA

Eric Lutz

Aff1 grid.21107.350000000121719311OncologyJohns Hopkins University Baltimore MD USA

Ivan Borrello

Aff11 grid.21107.350000000121719311Johns Hopkins School of Medicine 1650 Orleans St 21231 Baltimore MD USA

Daniela Bota

1Unviersity of California, Irvine, Orange, USA

Paul Swiecicki

5University of Michigan, Ann Arbor, MI, USA

Lakshmi Rudraraju

1WindMIL Therapeutics, Baltimore, MD, USA

Elizabeth DeOliveira

1WindMIL Therapeutics, Baltimore, MD, USA

Amanda Seiz

1WindMIL Therapeutics, Baltimore, MD, USA

Monil Shah

1WindMIL Therapeutics, Baltimore, MD, USA

Celine Colmenares

2University of California – Irvine, Irvine, CA, USA

Beverly Dan Fu

2University of California – Irvine, Irvine, CA, USA

Collin Brummel

3University of Michigan, Ann Arbor, MI, USA

Chad Brenner

3University of Michigan, Ann Arbor, MI, USA

Nicole Fredrich

4Providence Portland Medical Center, Portland, OR, USA

Eleni Efstatihiou

5The University of Texas MD Anderson Canc, Houston, TX, USA

Kimberly Noonan

1WindMIL Therapeutics, Baltimore, MD, USA